Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 7/20 | 0.67 |
| ▸ | F2 | P00734 | 2/20 | 0.61 |
| ▸ | TMPRSS4 | Q9NRS4 | 2/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | TAAR1 | Q96RJ0 | 8/20 | 0.53 |
| ▸ | DRD2 | P14416 | 1/20 | 0.48 |
| ▸ | DRD1 | P21728 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3190954 | 0.85 | HTR6 (0.51) | HTR6F2TMPRSS4TP53CYP1A2 | |
| Hydrochloric Acid SCHEMBL21199322 | 0.83 | HTR6 (0.50) | HTR6F2TMPRSS4TP53CYP1A2 | |
| SCHEMBL3735049 | 0.83 | HTR6 (0.69) | HTR6TAAR1DRD2DRD1CA12 | |
| SCHEMBL30839505 | 0.83 | HTR6 (0.69) | HTR6TAAR1DRD2DRD1CA12 | |
| SCHEMBL2204086 | 0.81 | HTR6 (0.67) | HTR6TAAR1DRD2DRD1CA12 | |
| SCHEMBL10034885 | 0.81 | HTR6 (0.67) | HTR6F2TMPRSS4TP53CYP1A2 | |
| Hydrochloric Acid SCHEMBL15741790 | 0.80 | HTR6 (0.65) | HTR6F2TMPRSS4TAAR1DRD2 | |
| SCHEMBL23665676 | 0.77 | ALDH1A1 (0.43) | HTR6CYP1A2CA2 | |
| SCHEMBL17315295 | 0.77 | HTR6 (0.61) | HTR6F2TMPRSS4TP53CYP1A2 | |
| SCHEMBL11207039 | 0.77 | NPC1 (0.42) | HTR6F2TMPRSS4TP53CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260021192-A1 | PROTEINS HAVING A COVALENT WARHEAD | TOPAZ THERAPEUTICS INC (US) | 2026-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260021192-A1 | PROTEINS HAVING A COVALENT WARHEAD | RIOX2, ORC3, DCLRE1A | HTR6 4206/4885F2 3542/4885TMPRSS4 2353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.